5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.01▼ | 9.11▼ | 9.14▼ | 8.56▲ | 7.82▲ |
MA10 | 9.07▼ | 9.14▼ | 9.13▼ | 8.30▲ | 6.40▲ |
MA20 | 9.11▼ | 9.15▼ | 8.95▲ | 7.27▲ | 6.61▲ |
MA50 | 9.15▼ | 8.70▲ | 8.36▲ | 5.88▲ | 5.57▲ |
MA100 | 9.13▼ | 8.30▲ | 7.67▲ | 6.24▲ | 6.52▲ |
MA200 | 8.99▼ | 7.54▲ | 6.69▲ | 5.84▲ | 9.49▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.019▼ | -0.045▼ | -0.034▼ | 0.155▲ | 0.332▲ |
RSI | 32.053▼ | 47.769▼ | 56.908▲ | 73.070▲ | 65.206▲ |
STOCH | 16.482▼ | 51.353 | 47.848 | 81.342▲ | 77.583 |
WILL %R | -100.000▼ | -89.744▼ | -51.497 | -10.579▲ | -7.792▲ |
CCI | -135.497▼ | -110.920▼ | -77.836 | 111.709▲ | 147.178▲ |
Friday, August 08, 2025 12:49 PM
Verastem (VSTM) stock surges as the company's new ovarian cancer therapy sees a strong launch, boosting its Q2 revenue. Read more here.
|
Thursday, June 19, 2025 05:01 PM
Here are some recent analyst ratings: Guggenheim issued a "Buy" rating on 03/24/2025 H.C. Wainwright issued a "Buy" rating on 03/24/2025 RBC Capital issued a "Outperform" rating on 01/07/2025 BTIG ...
|
Thursday, April 10, 2025 11:13 AM
Fintel reports that on April 10, 2025, Jefferies initiated coverage of Verastem (NasdaqCM:VSTM) with a Buy recommendation. Analyst Price Forecast Suggests 148.38% Upside As of April 2, 2025, the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/08/25 | 9.08 | 9.33 | 8.86 | 8.98 | 2,986,122 |
22/08/25 | 8.61 | 9.40 | 8.55 | 9.08 | 4,816,965 |
21/08/25 | 8.27 | 8.78 | 8.27 | 8.63 | 2,867,613 |
20/08/25 | 7.83 | 8.34 | 7.55 | 8.32 | 4,058,586 |
19/08/25 | 7.97 | 8.03 | 7.71 | 7.79 | 1,828,400 |
18/08/25 | 8.24 | 8.30 | 7.91 | 7.97 | 1,357,000 |
15/08/25 | 7.52 | 8.30 | 7.51 | 8.22 | 2,829,921 |
14/08/25 | 8.26 | 8.356 | 7.44 | 7.73 | 3,567,544 |
13/08/25 | 8.30 | 8.76 | 8.01 | 8.02 | 4,731,900 |
12/08/25 | 7.70 | 8.30 | 7.48 | 8.21 | 3,613,600 |
|
|
||||
|
|
||||
|
|